FDA Emphasizes “Deregulatory” Efforts In Mobile Medical Apps Final Guidance
This article was originally published in The Gray Sheet
Executive Summary
In a long-awaited final guidance, FDA affirmed its plan to practice enforcement discretion for most mobile medical apps, except those applications that present the same risks as conventional FDA-regulated devices. Some digital health stakeholders praised the guidance, while others wished FDA has waited.
You may also be interested in...
Get 'HIP'AA To Digital Medtech Law: More Than Just FDA To Worry About
The digital medtech sector is growing fast. As new companies enter the space, they are going to face oversight from a slew of government agencies and statutes. While FDA is an important focus for medtech, patient privacy and cybersecurity challenges for digital products raise other, significant compliance challenges. Medtech Insight discussed the range of hurdles the digital medtech industry faces with attorneys from Akin Gump.
Optometrists Group Says FDA Should Regulate Online Eye-Test Provider
Opternative allows consumers to take an eye test via their computer or smartphone, practices the American Optometric Association said could pose a risk to patient safety. The trade group wants FDA to require an approval for the service.
Optometrists Group Says FDA Should Regulate Online Eye-Test Provider
Opternative allows consumers to take an eye test via their computer or smartphone, practices the American Optometric Association said could pose a risk to patient safety. The trade group wants FDA to require an approval for the service.